Cigarette manufacturers plummeted Friday on news that the U.S. Food and Drug Administration would take steps to limit cigarette
nicotine to non-addictive levels.
“The overwhelming amount of death and disease attributable to tobacco is caused by addiction to cigarettes – the only legal
consumer product that, when used as intended, will kill half of all long-term users,” FDA Commissioner Scott Gottlieb said in a
press release. “Unless we change course, 5.6
million young people alive today will die prematurely later in life from tobacco use. Envisioning a world where cigarettes would no
longer create or sustain addiction, and where adults who still need or want nicotine could get it from alternative and less harmful
sources, needs to be the cornerstone of our efforts – and we believe it’s vital that we pursue this common ground.”
In The Details
The FDA will open public dialogue on the possibility of implementing more restrictive regulations on tobacco products and will
solicit input on related public health issues, such as the marketing of flavored products enticing to children.
“Lowering nicotine levels could decrease the likelihood that future generations become addicted to cigarettes and allow more
currently addicted smokers to quit,” the press release read.
The measure is an extension of the Family Smoking Prevention and Tobacco Control Act meant to protect children from negative
health effects.
To ease the burden on manufacturers and allow more time to develop safer products, the FDA is extending the timeline to submit
review applications for newly regulated products, such as cigars, pipe tobacco and hookah tobacco, to August 2018. Applications for
non-combustible products will be due in August 2022.
Not All Bad?
Some consider the news an ultimate positive.
"We see this as a positive for future profit growth as it could lead to positive volume growth in vapour and also more
favourable tax treatment than seen currently," a Jefferies analysts wrote in a mid-morning note. "Key now will be who is positioned
to take advantage of this shift."
Shares recovered slightly following the analysis.
At time of publication, British American Tobacco PLC (ADR) (NYSE: BTI) was down 10.4 percent, Altria Group Inc (NYSE: MO) 11.2 percent, Philip Morris International Inc. (NYSE:
PM) 3.5 percent and Vector Group Ltd (NYSE:
VGR) 3.1 percent.
Latest Ratings for BTI
Date |
Firm |
Action |
From |
To |
Mar 2017 |
Argus Research |
Upgrades |
Hold |
Buy |
Nov 2016 |
Morgan Stanley |
Upgrades |
Equal-Weight |
Overweight |
Sep 2016 |
Investec |
Upgrades |
Hold |
Buy |
View More Analyst Ratings for
BTI
View the Latest Analyst Ratings
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.